| Population pharmacokinetics of meropenem in plasma and subcutis from patients on extracorporeal membrane oxygenation treatment P Hanberg, K Öbrink-Hansen, A Thorsted, M Bue, M Tøttrup, LE Friberg, ... Antimicrobial agents and chemotherapy 62 (5), 10.1128/aac. 02390-17, 2018 | 62 | 2018 |
| Population pharmacokinetics of piperacillin in sepsis patients: should alternative dosing strategies be considered? MG Andersen, A Thorsted, M Storgaard, AN Kristoffersson, LE Friberg, ... Antimicrobial agents and chemotherapy 62 (5), 10.1128/aac. 02306-17, 2018 | 44 | 2018 |
| Population pharmacokinetics of piperacillin in plasma and subcutaneous tissue in patients on continuous renal replacement therapy M Bue, T Sou, ASL Okkels, P Hanberg, A Thorsted, LE Friberg, ... International Journal of Infectious Diseases 92, 133-140, 2020 | 26 | 2020 |
| A non-linear mixed effect model for innate immune response: In vivo kinetics of endotoxin and its induction of the cytokines tumor necrosis factor alpha and … A Thorsted, S Bouchene, E Tano, M Castegren, M Lipcsey, J Sjölin, ... PloS one 14 (2), e0211981, 2019 | 24 | 2019 |
| Population pharmacokinetics of piperacillin following continuous infusion in critically ill patients and impact of renal function on target attainment V Klastrup, A Thorsted, M Storgaard, S Christensen, LE Friberg, ... Antimicrobial agents and chemotherapy 64 (7), 10.1128/aac. 02556-19, 2020 | 23 | 2020 |
| Pharmacodynamics of immune response biomarkers of interest for evaluation of treatment effects in bacterial infections A Thorsted, EI Nielsen, LE Friberg International Journal of Antimicrobial Agents, 106059, 2020 | 19 | 2020 |
| Extension of pharmacokinetic/pharmacodynamic time-kill studies to include lipopolysaccharide/endotoxin release from Escherichia coli exposed to cefuroxime A Thorsted, E Tano, K Kaivonen, J Sjölin, LE Friberg, EI Nielsen Antimicrobial Agents and Chemotherapy 64 (4), 10.1128/aac. 02070-19, 2020 | 19* | 2020 |
| Piperacillin pharmacokinetics and target attainment in children with cancer and fever: Can we optimize our dosing strategy? SF Maarbjerg, A Thorsted, A Kristoffersson, LE Friberg, EI Nielsen, ... Pediatric blood & cancer 66 (6), e27654, 2019 | 18 | 2019 |
| Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen A Thorsted, AN Kristoffersson, SF Maarbjerg, H Schrøder, M Wang, ... Journal of Antimicrobial Chemotherapy 74 (10), 2984-2993, 2019 | 12 | 2019 |
| Pharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis … AM Novakovic, A Thorsted, E Schindler, S Jönsson, A Munafo, ... The Journal of Clinical Pharmacology 58 (10), 1284-1294, 2018 | 9 | 2018 |
| Translational mixed‐effects PKPD modelling of recombinant human growth hormone–from hypophysectomized rat to patients A Thorsted, P Thygesen, H Agersø, T Laursen, M Kreilgaard British journal of pharmacology 173 (11), 1742-1755, 2016 | 7 | 2016 |
| Continuous infusion of piperacillin‐tazobactam significantly improves target attainment in children with cancer and fever SF Maarbjerg, A Thorsted, LE Friberg, EI Nielsen, M Wang, H Schrøder, ... Cancer Reports 5 (10), e1585, 2022 | 2 | 2022 |
| Population Pharmacokinetics of Flucloxacillin In Bone and Soft Tissue–Standard Dosing is Not Sufficient to Achieve Therapeutic Concentrations K Öbrink-Hansen, AD Pham, M Bue, P Hanberg, M Bendtsen, J Slater, ... Pharmaceutical research 39 (7), 1633-1643, 2022 | 2 | 2022 |
| Pharmacometrics to characterize innate immune response and antibacterial treatments A Thorsted Acta Universitatis Upsaliensis, 2020 | 1 | 2020 |
| Predicting the Long‐Term Effects of Therapeutic Neutralization of Oncostatin M on Human Hematopoiesis A Thorsted, C Zecchin, A Berges, MO Karlsson, LE Friberg Clinical Pharmacology & Therapeutics, 2024 | | 2024 |
| Model‐based assessment of neutrophil‐mediated phagocytosis and digestion of bacteria across in vitro and in vivo studies A Thorsted, AD Pham, LE Friberg, EI Nielsen CPT: Pharmacometrics & Systems Pharmacology 12 (12), 1972-1987, 2023 | | 2023 |
| Optimization of Piperacillin-Tazobactam Treatment in Pediatric Oncology Patients with Fever-a Prospective Study “: Presented as an oral presentation at the NOPHO 36th Annual … SF Maarbjerg, A Thorsted, AN Kristoffersson, LE Friberg, EI Nielsen, ... | | 2018 |
